Synthesis and evaluation of novel two-photon fluorescence probes for in vivo imaging of amylin aggregates in the pancreas
Source abstract
Abstract
Abstract The deposition of islet amyloid consisting of amylin aggregates is one of the hallmarks of type 2 diabetes mellitus (T2DM). Therefore, the amylin aggregate is regarded as an attractive target for diagnosis, treatment and elucidation of the pathogenic mechanism of T2DM. However, no fluorescence probe for in vivo imaging of amylin aggregates has been reported. In this study, we evaluated four fluorescent probes (DANIRs) including two novel compounds (DANIR-OH 2b and DANIR-OH 2c) for two-photon fluorescence imaging of amylin aggregates in the pancreas. All DANIRs showed binding affinity for amylin aggregates and clearly stained amylin aggregates in pancreatic sections of the islet amylin model mice and T2DM patients in in vitro. In an ex vivo fluorescence staining study, these probes also bound to amylin aggregates in the pancreas of the islet amylin model mice. Furthermore, in an in vivo two-photon fluorescence imaging study, we clearly imaged the amylin aggregates after injecting DANIRs via the tail vein of the islet amyloid model mice. The results suggest that DANIRs may be useful for two-photon fluorescence imaging of amylin aggregates in the living mouse pancreas.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Alzheimer's disease research and treatments · Neuroinflammation and Neurodegeneration Mechanisms · Advanced Glycation End Products research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (36)
Show source-provided references
1. 2015
2. Current prevalence of Type 1 and Type 2 diabetes in adults and children in the UK10.1111/dme.12791 ↗
3. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications
4. Islet amyloid and type 2 diabetes mellitus10.1056/NEJM200008103430607 ↗
5. Amyloidogenicity, cytotoxicity, and receptor activity of bovine amylin: implications for xenobiotic transplantation and the design of nontoxic amylin variants10.1021/acschembio.8b00690 ↗
6. IAPP/amylin and β-cell failure: implication of the risk factors of type 2 diabetes10.1007/s13340-018-0347-1 ↗
7. Type 2 diabetes as a protein misfolding disease10.1016/j.molmed.2015.04.005 ↗
8. IAPP in type II diabetes: basic research on structure, molecular interactions, and disease mechanisms suggests potential intervention strategies10.1016/j.bbamem.2018.02.020 ↗
9. Islet amyloid polypeptide and type 2 diabetes10.1016/S0531-5565(03)00004-4 ↗
10. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers10.1016/S1474-4422(12)70291-0 ↗
11. Amyloid fibril formation from full-length and fragments of amylin10.1006/jsbi.2000.4268 ↗
12. Distinct oligomerization and fibrillization dynamics of amyloid core sequences of amyloid-β and islet amyloid polypeptide10.1039/C7CP05695H ↗
13. Novel benzofuran derivatives for PET imaging of β-amyloid plaques in Alzheimer's disease brains10.1021/jm051176k ↗
14. Novel 18F-labeled benzofuran derivatives with improved properties for positron emission tomography (PET) imaging of β-amyloid plaques in Alzheimer's brains10.1021/jm200057u ↗
15. Development of novel 123I-labeled pyridyl benzofuran derivatives for SPECT imaging of β-amyloid plaques in alzheimer's disease10.1371/journal.pone.0074104 ↗
16. 18F-FPYBF-2, a new F-18-labelled amyloid imaging PET tracer: first experience in 61 volunteers and 55 patients with dementia10.1007/s12149-018-1236-1 ↗
17. Feasibility of amylin imaging in pancreatic islets with β-amyloid imaging probes10.1038/srep06155 ↗
18. Development of 99mtc-labeled pyridyl benzofuran derivatives to detect pancreatic amylin in islet amyloid model mice10.1021/acs.bioconjchem.6b00174 ↗
19. Molecular imaging in drug development10.1038/nrd2290 ↗
20. Two-photon absorbing dyes with minimal autofluorescence in tissue imaging: application to in vivo imaging of amyloid-β plaques with a negligible background signal10.1021/jacs.5b03548 ↗
21. BODIPY-based molecular probe for imaging of cerebral β-amyloid plaques10.1021/cn3000058 ↗
22. Molecular imaging of β-amyloid plaques with near-infrared boron dipyrromethane (BODIPY)-based fluorescent probes10.2310/7290.2013.00049 ↗
23. Smart near-infrared fluorescence probes with donor-acceptor structure for in vivo detection of β-amyloid deposits10.1021/ja4052922 ↗
24. In vivo fluorescence imaging of β-amyloid plaques with push-pull dimethylaminothiophene derivatives10.1039/C5CC06628J ↗
25. Promising two-photon probes for in vivo detection of β amyloid deposits10.1039/C4CC03897E ↗
26. A two-photon fluorescent probe for amyloid-β plaques in living mice10.1039/c2cc38570h ↗
27. Small-molecule two-photon probes for bioimaging applications10.1021/cr5004425 ↗
28. A quadrupolar two-photon fluorescent probe for in vivo imaging of amyloid-β plaques10.1039/C6SC00355A ↗
29. Deep insights: intravital imaging with two-photon microscopy10.1007/s00424-016-1832-7 ↗
30. Intravital Forster resonance energy transfer imaging reveals osteopontin-mediated polymorphonuclear leukocyte activation by tumor cell emboli10.1111/cas.13132 ↗
31. The synthesis and evaluation of near-infrared probes with barbituric acid acceptors for in vivo detection of amyloid plaques10.1039/C5CC03662C ↗
32. Smart D-pi-A type near-infrared Aβ probes: effects of a marked pi bridge on optical and biological properties10.1021/acs.analchem.7b02246 ↗
33. A difluoroboron beta-diketonate probe shows “Turn-on” near-infrared fluorescence specific for tau fibrils10.1021/acschemneuro.7b00224 ↗
34. Novel D-A-D based near-infrared probes for the detection of β-amyloid and Tau fibrils in Alzheimer's disease10.1039/C8CC05259J ↗
35. In vivo optical imaging of amyloid aggregates in brain: design of fluorescent markers10.1002/anie.200500845 ↗
36. Design, synthesis, and testing of difluoroboron-derivatized curcumins as near-infrared probes for in vivo detection of amyloid-β deposits10.1021/ja9047043 ↗